What is the Optimal BCG Dose in Non–Muscle-Invasive Bladder Cancer?
Author:
Publisher
Elsevier BV
Subject
Urology
Reference11 articles.
1. A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27mg) versus very low-dose bacillus Calmette-Guerin (13.5mg) versus mitomycin C;Ojea;Eur Urol,2007
2. The use of intravesical BCG in superficial bladder tumors. An overview;Witjes;Urol Int,1990
3. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy;Shintani;Int J Urol,2007
4. Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guérin response of superficial bladder cancer during induction course and maintenance therapy;Saint;Int J Cancer,2003
5. A randomized prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumors and primary carcinoma in situ of the urinary bladder. Intravesical instillations in superficial bladder cancer;Witjes;Eur J Cancer,1993
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting Taurine Transporter (TauT) for Cancer Immunotherapy of p53 Mutation Mediated Cancers – Molecular Basis and Preclinical Implication;Advances in Experimental Medicine and Biology;2019
2. Optimal duration and dosage of BCG intravesical immunotherapy: A free final time optimal control approach;Mathematical Methods in the Applied Sciences;2018-01-17
3. The Dose-Response Relationship of bacillus Calmette-Guérin and Urothelial Carcinoma Cell Biology;Journal of Urology;2016-06
4. Investigational therapies for non-muscle invasive bladder cancer;Expert Opinion on Investigational Drugs;2010-01-17
5. Assessment of angiogenic factor, vascular endothelial growth factor, serum and urine level changes in superficial bladder tumor immunotherapy by intravesical Bacillus Calmette-Guerin;Urology Annals;2010
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3